Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone
Conditions
- Clinical Response
- Histopathological Response
- Prognosis
Interventions
- DRUG: first-line chemotherapy
Sponsor
Peking University People's Hospital
Collaborators